New app aims to tackle diabetes stress in School-Age children
NCT ID NCT05268250
First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times
Summary
This study tests a mobile health program called R2D2 designed to reduce diabetes distress in children aged 8-12 with type 1 diabetes and their parents. The program uses cognitive behavioral therapy, mindfulness, and behavioral strategies to help families cope. Researchers will measure changes in blood sugar control and emotional well-being in 180 participants.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
R2D2 mHealth intervention (behavioral therapy using cognitive behavioral therapy, mindfulness, and behavioral activation strategies)
What this could lead to
If it works, this could provide a scalable, low-cost way to help families manage the emotional burden of type 1 diabetes and improve children's blood sugar levels.
What could go wrong
This is an early feasibility and efficacy trial with only 180 participants, so results may not apply to everyone. The intervention is behavioral, so benefits may vary and long-term effects are unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Mercy Kansas City
Kansas City, Missouri, 64108, United States
-
Nemours Children's Health
Jacksonville, Florida, 32207, United States